NCT06066099View on ClinicalTrials.gov

Single Ascending Dose, Multiple Ascending Dose, Food Effect Study With AP31969

PHASE1CompletedINTERVENTIONAL

Enrollment

92

Participants

Timeline

Start Date

October 4, 2023

Primary Completion Date

March 14, 2025

Study Completion Date

March 14, 2025

Conditions

Healthy Volunteers

Interventions

DRUG

AP31969

Oral tablets

DRUG

Placebo

Oral tablets

Trial Locations (1)

9728

Acesion Pharma Investigational Site 10, Groningen

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Acesion Pharma

INDUSTRY